Pituitary Microadenoma Treated with Individualized Homeopathic Medicine: A Case ReportFunding None.
Background Pituitary adenomas are common benign tumors of the pituitary gland with an overall estimated prevalence of 16.7%. As per the revised World Health Organization (WHO) classification, these tumors are identified by their histological subtypes and are designated by their pituitary cell lineage instead of the hormone they produce. The lactotroph adenoma is the most common subtype of hormone-producing pituitary adenoma. Surgery is the mainstay of treatment, but complications are encountered. So far, there is no reported study evaluating individualized homeopathic intervention in pituitary adenoma in peer-reviewed journals.
Methods This case study describes a case of functional lactotroph microadenoma with history of failed surgical treatment and heavy intrasellar hemorrhage occurring during the surgery. Phosphorus was prescribed as an individualized homeopathic medicine on the basis of symptoms—hemorrhagic complication during surgical procedure and aggravation of headache thereafter.
Results There was a marked subjective improvement along with complete tumor regression, as evidenced by repeat magnetic resonance imaging scans. The Modified Naranjo Criteria total score was +10 out of a possible +13, providing some evidence to attribute the clinical outcome with the homeopathic intervention.
Conclusion This case study reconfirms the association between increased frequency of headaches and pituitary hemorrhage among cases of lactotroph adenoma. It also suggests that individualized homeopathic treatment may be helpful in pituitary adenomas with increased risk of complications such as intrasellar hemorrhage.
The author certifies that the patient completed a consent form in which she gave her consent for her medical images and other clinical information to be reported anonymously in an academic journal. The patient understands that her name and initials will not be published and that all due efforts are made to conceal her identity.
Received: 16 January 2020
Accepted: 20 April 2020
30 August 2020 (online)
© 2020. Thieme. All rights reserved.
The Faculty of Homeopathy
- 1 Ezzat S, Asa SL, Couldwell WT. et al. The prevalence of pituitary adenomas: a systematic review. Cancer 2004; 101: 613-619
- 2 Nishioka H, Inoshita N. New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathol 2018; 35: 57-61
- 3 Mansour AA, Alhamza AHA, Almomin AMSA. et al. Spectrum of pituitary disorders: a retrospective study from Basrah, Iraq. Version 2. F1000Research 2018; 7: 430
- 4 Tiwari S, Pant I, Chaturvedi S. Pituitary tumors: changing paradigms in understanding, nomenclature and the newer basis of classification. Astrocyte 2018; 4: 240-250
- 5 Ciccarelli A, Daly AF, Beckers A. The epidemiology of prolactinomas. Pituitary 2005; 8: 3-6
- 6 Papanastasiou L, Fountoulakis S, Pappa T. et al. Brain and optic chiasmal herniation following cabergoline treatment for a giant prolactinoma: wait or intervene?. Hormones (Athens) 2014; 13: 290-295
- 7 Hering C. Cinchona officinalis. In: Raue CG, Knerr CB, Mohr C. , eds. The Guiding Symptoms of Our Materia Medica. Vol. 4. New Delhi: B. Jain Publishers; 1993: 171-198
- 8 Schroyens F. Synthesis Repertorium Homeopathicum Syntheticum. 9.1 ed. New Delhi: B. Jain Publishers; 2011
- 9 van Haselen RA. Homeopathic clinical case reports: development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complement Ther Med 2016; 25: 78-85
- 10 Sarwar KN, Huda MSB, Van de Velde V. et al. The prevalence and natural history of pituitary hemorrhage in prolactinoma. J Clin Endocrinol Metab 2013; 98: 2362-2367